Page last updated: 2024-08-23

paroxetine and Abnormalities, Drug-Induced

paroxetine has been researched along with Abnormalities, Drug-Induced in 39 studies

Research

Studies (39)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (2.56)	18.7374
1990's	2 (5.13)	18.2507
2000's	16 (41.03)	29.6817
2010's	20 (51.28)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bérard, A; Boukhris, T; Chaabane, S; Iessa, N; Muanda, FT; Zhao, JP	1
Bérard, A; Boukhris, T; Chaabane, S; Muanda, FT; Zhao, J	1
Avgil, M; Clementi, M; Di Gianantonio, E; Diav-Citrin, O; Ornoy, A; Schaefer, C; Shechtman, S; Wajnberg, R; Weber-Schoendorfer, C; Weinbaum, D	1
Jureidini, J; Mintzes, B	1
Bellantuono, C; Gentile, S	1
Freeman, MP	1
Ephross, SA; Olshan, AF; Poole, C; Wurst, KE	1
Tanne, JH	1
Iannucci, AR; Scialli, AR	1
Bérard, A	1
Scialli, AR	1
Favrelière, S; Jaafari, N; Nourrisson, A; Pérault Pochat, MC	1
Einarson, A; Koren, G	1
Antonioli, L; Blandizzi, C; Colucci, R; Corona, T; Fornai, M; Mantarro, S; Montagnani, S; Pergola, A; Ruggiero, E; Scollo, C; Testi, A; Tuccori, M	1
Einarson, A	2
Aitchison, KJ; Keers, R	1
Aoun, J; Gorsane, MA; Krebs, MO; Soufia, M	1
Koren, G	1
Artama, M; Gissler, M; Malm, H; Ritvanen, A	1
Bozzo, P; Koren, G; Pupco, A	1
Einarson, A; Puryear, LJ; Spinelli, M	1
Evans, S; Gilbert, R; Nazareth, I; Petersen, I	1
Bérard, A; Crespin, S; Damase-Michel, C; Sheehy, O	1
Byatt, N; Deligiannidis, KM; Freeman, MP	1
Batash, D; Bulkowstein, M; Heyman, E; Keidar, R; Morag, I	1
Williams, M; Wooltorton, E	1
Källén, B; Otterblad Olausson, P	1
Cuzzell, JZ	1
Hallberg, P; Odlind, V; Sjöblom, V	1
Bérard, A; Blais, L; Oraichi, D; Ramos, E; Rey, E; St-André, M	1
Bar-Oz, B; Bérard, A; Boskovic, R; Einarson, A; Einarson, T; Koren, G; Malm, H; O'Brien, L	1
Cole, JA; Cosmatos, IS; Ephross, SA; Walker, AM	1
Bakker, MK; de Jong van den Berg, LT; de Walle, HE; Kölling, P; van den Berg, PB	1
DeSantis, M; Einarson, A; Einarson, TR; Kennedy, D; Koren, G; Malm, H; Panchaud, A; Paulus, WD; Pistelli, A	1
Brochu, J; Cook, L; Feldkamp, M; Koren, G; Kulin, NA; Matsui, D; Ormond, K; Pastuszak, A; Rieder, M; Sage, SR; Schick-Boschetto, B; Spivey, G; Stein-Schechman, AK	1
Baldwin, JA; Davidson, EJ; Pritchard, AL; Ridings, JE	1

Reviews

10 review(s) available for paroxetine and Abnormalities, Drug-Induced

Article	Year
The risk of major cardiac malformations associated with paroxetine use during the first trimester of pregnancy: a systematic review and meta-analysis. British journal of clinical pharmacology, 2016, Volume: 81, Issue:4 Topics: Abnormalities, Drug-Induced; Female; Heart Defects, Congenital; Humans; Maternal Exposure; Paroxetine; Pregnancy; Pregnancy Trimester, First; Risk Assessment; Selective Serotonin Reuptake Inhibitors	2016
Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of fetal major malformations: focus on paroxetine. The Journal of clinical psychiatry, 2009, Volume: 70, Issue:3 Topics: Abnormalities, Drug-Induced; Antidepressive Agents, Second-Generation; Controlled Clinical Trials as Topic; Cross-Sectional Studies; Depressive Disorder; Female; Humans; Infant, Newborn; Paroxetine; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Prospective Studies; Risk; Selective Serotonin Reuptake Inhibitors	2009
First trimester paroxetine use and the prevalence of congenital, specifically cardiac, defects: a meta-analysis of epidemiological studies. Birth defects research. Part A, Clinical and molecular teratology, 2010, Volume: 88, Issue:3 Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Adult; Female; Heart Defects, Congenital; Humans; Odds Ratio; Paroxetine; Pregnancy; Pregnancy Trimester, First; Selective Serotonin Reuptake Inhibitors	2010
[Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn]. L'Encephale, 2010, Volume: 36 Suppl 2 Topics: Abnormalities, Drug-Induced; Antidepressive Agents, Second-Generation; Depressive Disorder; Female; Gestational Age; Humans; Infant, Newborn; Paroxetine; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Risk; Secondary Prevention; Selective Serotonin Reuptake Inhibitors	2010
Use of selective serotonin reuptake inhibitors during pregnancy and risk of major and cardiovascular malformations: an update. Postgraduate medicine, 2010, Volume: 122, Issue:4 Topics: Abnormalities, Drug-Induced; Cardiovascular Abnormalities; Citalopram; Depression; Female; Fluoxetine; Fluvoxamine; Humans; Maternal-Fetal Exchange; Paroxetine; Pregnancy; Pregnancy Complications; Selective Serotonin Reuptake Inhibitors; Sertraline; Teratogens	2010
Gender differences in antidepressant drug response. International review of psychiatry (Abingdon, England), 2010, Volume: 22, Issue:5 Topics: Abnormalities, Drug-Induced; Antidepressive Agents; Antidepressive Agents, Tricyclic; Depression, Postpartum; Depressive Disorder; Drug Tolerance; Female; Humans; Male; Milk, Human; Paroxetine; Pregnancy; Prevalence; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sex Factors; Treatment Outcome; Women	2010
[SSRIs and pregnancy: a review of the literature]. L'Encephale, 2010, Volume: 36, Issue:6 Topics: Abnormalities, Drug-Induced; Antidepressive Agents; Depressive Disorder, Major; Drug-Related Side Effects and Adverse Reactions; Female; Heart Defects, Congenital; Humans; Infant, Newborn; Infant, Newborn, Diseases; Paroxetine; Pregnancy; Pregnancy Complications; Pregnancy Trimester, Third; Risk Assessment; Selective Serotonin Reuptake Inhibitors	2010
Publishing statistically significant results with questionable clinical importance: focus on antidepressant use in pregnancy. The Journal of clinical psychiatry, 2012, Volume: 73, Issue:11 Topics: Abnormalities, Drug-Induced; Antidepressive Agents; Bias; Causality; Compensation and Redress; Cross-Sectional Studies; Data Interpretation, Statistical; Depressive Disorder; Drug Utilization; Female; Heart Defects, Congenital; Humans; Infant, Newborn; Paroxetine; Preconception Care; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Product Surveillance, Postmarketing; Publishing; Risk Factors; Selective Serotonin Reuptake Inhibitors	2012
Antidepressant use in pregnancy: a critical review focused on risks and controversies. Acta psychiatrica Scandinavica, 2013, Volume: 127, Issue:2 Topics: Abnormalities, Drug-Induced; Antidepressive Agents; Depressive Disorder; Female; Humans; Infant, Newborn; Paroxetine; Persistent Fetal Circulation Syndrome; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Prenatal Exposure Delayed Effects; Risk Factors; Selective Serotonin Reuptake Inhibitors	2013
Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors. Clinical therapeutics, 2007, Volume: 29, Issue:5 Topics: Abnormalities, Drug-Induced; Adult; Amniocentesis; Antidepressive Agents, Second-Generation; Anxiety; Depression; Electrocardiography; Female; Humans; Infant, Newborn; Paroxetine; Pregnancy; Pregnancy Complications; Pregnancy Trimesters; Ultrasonography	2007

Other Studies

29 other study(ies) available for paroxetine and Abnormalities, Drug-Induced

Article	Year
Paroxetine use during pregnancy and the risk of cardiac defects. British journal of clinical pharmacology, 2016, Volume: 82, Issue:2 Topics: Abnormalities, Drug-Induced; Antidepressive Agents, Second-Generation; Female; Heart Defects, Congenital; Humans; Paroxetine; Pregnancy; Pregnancy Complications; Risk; Selective Serotonin Reuptake Inhibitors	2016
Paroxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational study. British journal of clinical pharmacology, 2008, Volume: 66, Issue:5 Topics: Abnormalities, Drug-Induced; Abortion, Induced; Adult; Antidepressive Agents, Second-Generation; Birth Weight; Case-Control Studies; Confidence Intervals; Drug Administration Schedule; Female; Fluoxetine; Gestational Age; Heart Defects, Congenital; Humans; Infant, Newborn; Maternal Age; Odds Ratio; Paroxetine; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Risk; Selective Serotonin Reuptake Inhibitors	2008
Should paroxetine be used to treat depression during pregnancy? The American journal of psychiatry, 2008, Volume: 165, Issue:11 Topics: Abnormalities, Drug-Induced; Antidepressive Agents, Second-Generation; Depressive Disorder; Drug-Related Side Effects and Adverse Reactions; Evidence-Based Medicine; Female; Heart Defects, Congenital; Humans; Infant, Newborn; Paroxetine; Pregnancy; Pregnancy Complications; Randomized Controlled Trials as Topic; Secondary Prevention; Substance Withdrawal Syndrome	2008
An imperfect literature and evidence-based medicine. The Journal of clinical psychiatry, 2009, Volume: 70, Issue:3 Topics: Abnormalities, Drug-Induced; Aged, 80 and over; Antidepressive Agents, Second-Generation; Depression, Postpartum; Evidence-Based Medicine; Female; Humans; Nortriptyline; Paroxetine; Pregnancy; Pregnancy Trimester, First; Randomized Controlled Trials as Topic; Review Literature as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Behavior	2009
GSK is sued in US over alleged link of paroxetine to birth defects. BMJ (Clinical research ed.), 2009, Oct-12, Volume: 339 Topics: Abnormalities, Drug-Induced; Antidepressive Agents, Second-Generation; Drug Industry; Heart Defects, Congenital; Humans; Infant; Male; Paroxetine; Teratogens; United States	2009
Whole embryo culture and the identification of "teratogenicity". Reproductive toxicology (Elmsford, N.Y.), 2010, Volume: 29, Issue:2 Topics: Abnormalities, Drug-Induced; Animals; Cardiovascular Abnormalities; Disease Models, Animal; Embryo Culture Techniques; Embryo, Mammalian; Female; Humans; Maternal Exposure; Paroxetine; Selective Serotonin Reuptake Inhibitors; Teratogens; Terminology as Topic	2010
Paroxetine exposure during pregnancy and the risk of cardiac malformations: what is the evidence? Birth defects research. Part A, Clinical and molecular teratology, 2010, Volume: 88, Issue:3 Topics: Abnormalities, Drug-Induced; Adult; Data Interpretation, Statistical; Evidence-Based Medicine; Female; Heart Defects, Congenital; Humans; Meta-Analysis as Topic; Paroxetine; Pregnancy; Pregnancy Trimester, First; Selective Serotonin Reuptake Inhibitors; Uncertainty	2010
Paroxetine exposure during pregnancy and cardiac malformations. Birth defects research. Part A, Clinical and molecular teratology, 2010, Volume: 88, Issue:3 Topics: Abnormalities, Drug-Induced; Animals; Data Interpretation, Statistical; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Heart Defects, Congenital; Humans; Meta-Analysis as Topic; Mice; Odds Ratio; Paroxetine; Pregnancy; Pregnancy Trimester, First; Rabbits; Rats; Selective Serotonin Reuptake Inhibitors; Species Specificity; Uncertainty	2010
First trimester exposure to paroxetine and prevalence of cardiac defects: Meta-analysis of the literature: Unfortunately incomplete. Birth defects research. Part A, Clinical and molecular teratology, 2010, Volume: 88, Issue:7 Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Adult; Female; Heart Defects, Congenital; Humans; Meta-Analysis as Topic; Paroxetine; Pregnancy; Pregnancy Trimester, First; Selective Serotonin Reuptake Inhibitors	2010
Paroxetine use in pregnancy and increased risk of heart defects: Evaluating the evidence. Canadian family physician Medecin de famille canadien, 2010, Volume: 56, Issue:8 Topics: Abnormalities, Drug-Induced; Adult; Depression; Evidence-Based Medicine; Female; Heart Defects, Congenital; Humans; Meta-Analysis as Topic; Paroxetine; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Selective Serotonin Reuptake Inhibitors; Uncertainty	2010
The effect of ascertainment bias in evaluating gestational antidepressant exposure. Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharmacologie clinique, 2011, Volume: 18 Topics: Abnormalities, Drug-Induced; Antidepressive Agents, Second-Generation; Female; Heart Septal Defects, Ventricular; Humans; Paroxetine; Pregnancy	2011
Selective serotonin reuptake inhibitors and risk for major congenital anomalies. Obstetrics and gynecology, 2011, Volume: 118, Issue:1 Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Alcohol Drinking; Female; Finland; Fluoxetine; Heart Septal Defects, Ventricular; Humans; Middle Aged; Paroxetine; Pregnancy; Risk Assessment; Selective Serotonin Reuptake Inhibitors; United States; Young Adult	2011
Selective serotonin reuptake inhibitors and risk for major congenital anomalies. Obstetrics and gynecology, 2011, Volume: 118, Issue:4 Topics: Abnormalities, Drug-Induced; Female; Fluoxetine; Humans; Paroxetine; Pregnancy; Selective Serotonin Reuptake Inhibitors	2011
Selective serotonin reuptake inhibitors and risk for major congenital anomalies. Obstetrics and gynecology, 2011, Volume: 118, Issue:6 Topics: Abnormalities, Drug-Induced; Female; Fluoxetine; Humans; Paroxetine; Pregnancy; Selective Serotonin Reuptake Inhibitors	2011
Selective serotonin reuptake inhibitors and risk for major congenital anomalies. Obstetrics and gynecology, 2012, Volume: 119, Issue:1 Topics: Abnormalities, Drug-Induced; Female; Fluoxetine; Humans; Paroxetine; Pregnancy; Selective Serotonin Reuptake Inhibitors	2012
Paroxetine use during pregnancy and perinatal outcomes including types of cardiac malformations in Quebec and France: a short communication. Current drug safety, 2012, Volume: 7, Issue:3 Topics: Abnormalities, Drug-Induced; Antidepressive Agents, Second-Generation; Female; France; Heart Defects, Congenital; Humans; Infant, Newborn; Paroxetine; Pregnancy; Prevalence; Quebec	2012
Paroxetine use throughout pregnancy: does it pose any risk to the neonate? Journal of toxicology. Clinical toxicology, 2004, Volume: 42, Issue:1 Topics: Abnormalities, Drug-Induced; Adult; Electroencephalography; Female; Humans; Hyperalgesia; Infant, Newborn; Male; Maternal Age; Maternal Exposure; Paroxetine; Pregnancy; Pregnancy, High-Risk; Selective Serotonin Reuptake Inhibitors	2004
Paroxetine (Paxil) and congenital malformations. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2005, Nov-22, Volume: 173, Issue:11 Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Databases, Factual; Female; Humans; Incidence; Middle Aged; Paroxetine; Pregnancy; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; United States	2005
Antidepressant drugs during pregnancy and infant congenital heart defect. Reproductive toxicology (Elmsford, N.Y.), 2006, Volume: 21, Issue:3 Topics: Abnormalities, Drug-Induced; Antidepressive Agents; Clomipramine; Female; Heart Defects, Congenital; Humans; Paroxetine; Pregnancy; Prenatal Exposure Delayed Effects; Sweden	2006
Paroxetine may increase risk for congenital malformations. Dermatology nursing, 2006, Volume: 18, Issue:1 Topics: Abnormalities, Drug-Induced; Antidepressive Agents, Second-Generation; Female; Heart Defects, Congenital; Humans; Paroxetine; Pregnancy; Pregnancy Trimester, First; Teratogens	2006
Selective serotonin-reuptake inhibitors and persistent pulmonary hypertension of the newborn. The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20 Topics: Abnormalities, Drug-Induced; Confounding Factors, Epidemiologic; Female; Heart Defects, Congenital; Humans; Infant, Newborn; Mental Disorders; Paroxetine; Persistent Fetal Circulation Syndrome; Pregnancy; Pregnancy Complications; Selective Serotonin Reuptake Inhibitors	2006
SSRI antidepressants and birth defects. Prescrire international, 2006, Volume: 15, Issue:86 Topics: Abnormalities, Drug-Induced; Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Cohort Studies; Cost-Benefit Analysis; Denmark; Depression; Female; Heart Defects, Congenital; Humans; Infant, Newborn; Paroxetine; Pregnancy; Prenatal Exposure Delayed Effects; Selective Serotonin Reuptake Inhibitors; Sweden; Teratogens; United States	2006
First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage. Birth defects research. Part B, Developmental and reproductive toxicology, 2007, Volume: 80, Issue:1 Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Antidepressive Agents, Second-Generation; Dose-Response Relationship, Drug; Female; Heart Defects, Congenital; Humans; Middle Aged; Paroxetine; Pregnancy; Pregnancy Trimester, First; Selective Serotonin Reuptake Inhibitors	2007
Paroxetine in the first trimester and the prevalence of congenital malformations. Pharmacoepidemiology and drug safety, 2007, Volume: 16, Issue:10 Topics: Abnormalities, Drug-Induced; Adult; Cardiovascular Abnormalities; Cohort Studies; Female; Humans; Infant, Newborn; Male; Odds Ratio; Paroxetine; Pregnancy; Pregnancy Trimester, First; Prevalence; Selective Serotonin Reuptake Inhibitors	2007
Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands. British journal of clinical pharmacology, 2008, Volume: 65, Issue:4 Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Depressive Disorder; Female; Fetal Development; Humans; Male; Middle Aged; Netherlands; Paroxetine; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pregnancy Trimesters; Risk Assessment; Selective Serotonin Reuptake Inhibitors	2008
Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy. The American journal of psychiatry, 2008, Volume: 165, Issue:6 Topics: Abnormalities, Drug-Induced; Antidepressive Agents, Second-Generation; Depressive Disorder, Major; Female; Heart Defects, Congenital; Humans; Infant; Infant, Newborn; Odds Ratio; Paroxetine; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Risk Assessment	2008
Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study. JAMA, 1998, Feb-25, Volume: 279, Issue:8 Topics: 1-Naphthylamine; Abnormalities, Drug-Induced; Adult; Antidepressive Agents; Cohort Studies; Female; Fluvoxamine; Humans; Infant, Newborn; Paroxetine; Pregnancy; Pregnancy Outcome; Pregnancy Trimester, First; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline	1998
Serotonin reuptake inhibitor antidepressants and pregnancy: many unanswered questions. Prescrire international, 1999, Volume: 8, Issue:43 Topics: Abnormalities, Drug-Induced; Antidepressive Agents, Second-Generation; Child; Child, Preschool; Clinical Trials as Topic; Depressive Disorder; Female; Fluoxetine; Fluvoxamine; Humans; Infant; Infant, Newborn; Paroxetine; Pregnancy; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	1999
The reproductive toxicology of paroxetine. Acta psychiatrica Scandinavica. Supplementum, 1989, Volume: 350 Topics: Abnormalities, Drug-Induced; Animals; Antidepressive Agents; Body Weight; Dose-Response Relationship, Drug; Female; Litter Size; Paroxetine; Piperidines; Pregnancy; Pregnancy, Animal; Rabbits; Rats; Serotonin Antagonists	1989